Synapse - Ellen Basu

Results (101)

Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma

Journal Article

Tringale, K. R.; Wolden, S. L.; Casey, D. L.; Kushner, B. H.; Luo, L.; Pandit-Taskar, N.; Souweidane, M.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; more...
Pediatric Blood and Cancer (2023)

Fulltext@MSK | Save

Immunotherapy with anti-G(D2) monoclonal antibody in infants with high-risk neuroblastoma

Journal Article

Kushner, B. H.; Modak, S.; Kramer, K.; Basu, E. M.; Iglesias-Cardenas, F.; Roberts, S. S.; Cheung, N. K. V.
International Journal of Cancer (2023)

Fulltext@MSK | Save

Oral beta-glucan enhanced anti-ganglioside antibody titer after vaccination against high- risk neuroblastoma: Results of a randomized trial

Meeting Abstract

Cheung, I. Y.; Mauguen, A.; Feng, Y.; Ragupathi, G.; Basu, E.; Roberts, S. S.; Modak, S.; Kushner, B. H.; Cheung, N. K. V.
Cancer Research (2022)

Fulltext@MSK | Save

Plasma cell-free DNA analysis uncovered tumor heterogeneity and clonal evolution during treatment for relapsed neuroblastoma

Meeting Abstract

Cardenas, F. I.; Kothari, P.; Tsui, D.; Basu, E.; Roberts, S.; Cheung, N. K.; Kushner, B.; Modak, S.
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Entrectinib in children, adolescents and young adults with extracranial solid or primary CNS tumours harbouring NTRK1/2/3, ROS1, or ALK fusions: Updated data from STARTRK-NG

Meeting Abstract

Desai, A.; Robinson, G.; Basu, E.; Foster, J.; Sabnis, A.; Maese, L.; Yoon, J.; Cash, T.; Pratilas, C.; Wu, Y.; more...
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study

Meeting Abstract

Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)

Journal Article

Desai, A. V.; Robinson, G. W.; Gauvain, K.; Basu, E. M.; Macy, M. E.; Maese, L.; Whipple, N. S.; Sabnis, A. J.; Foster, J. H.; Shusterman, S.; more...
Neuro-Oncology (2022)

Fulltext@MSK | Save

Improving fellow involvement in new patient visits: A single center quality improvement initiative

Meeting Abstract

Satty, A.; Guskin, J.; Peterson, J.; Yu, J.; Humphrey, J.; Reyes, J.; Glincher, R.; Ackerman, J.; Basu, E.; Roberts, S.
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

ALK inhibitors for treatment of adult-onset neuroblastoma

Meeting Abstract

Stiefel, J.; Kushner, B.; Roberts, S.; Basu, E.; Modak, S.
Pediatric Blood and Cancer (2021)

Fulltext@MSK | Save

Skeletal muscle metastases in neuroblastoma: An ostensible "forme fruste" of stage MS disease

Meeting Abstract

Fong, C.; Kushner, B.; Di Giannatale, A.; Roberts, S.; Basu, E.; Price, A.; Cheung, N. K.; Modak, S.
Pediatric Blood and Cancer (2021)

Fulltext@MSK | Save

Ellen Marlese Basu

Results (101)

Journal Article

Journal Article

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Journal Article

Meeting Abstract

Meeting Abstract

Meeting Abstract